Skip to main content
. 2013 Jun 21;8(6):e66708. doi: 10.1371/journal.pone.0066708

Table 2. CAs used by the participants.

Class CA Number of Patients (%)
DHP Amlodipine 39 (45.9%)
DHP Felodipine 13 (15.3%)
DHP Lercanidipine 12 (14.1%)
Non-DHP Diltiazem 10 (11.8%)
DHP Nifedipine 8 (9.4%)
Non-DHP Verapamil 1 (1.2%)
Mixed Amlodipine/Diltiazem 1 (1.2%)
Mixed Felodipine/Verapamil 1 (1.2%)